Krishnaswamy Yeleswaram sold $2.5M of Rapport Therapeutics, Inc. (RAPP) stock

Krishnaswamy Yeleswaram, Chief Development Officer of Rapport Therapeutics, Inc. (RAPP), sold 50,160 shares of RAPP stock worth $2.5M, per an SEC Form 4 filed Aug 26, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade happened on Aug 24, 2026, 2 days before it was made public.

RAPP has moved -19.6% since the trade date, from $49.33 to $39.66 (Sep 21, 2026 close).